Loading...

NDRA ENDRA LIFE SCIENCES INC Management Changes 8-K Filing

NDR

NDR

ENDRA LIFE SCIENCES INC

(NDRA)

2024 8-K

Summary

Summary

Stock Offering Agreement

Digital Asset Launch

Technical Correction

Fundraising Announcement

Cryptocurrency Treasury Str...

Equity Offerings

Investor Meetings

Failure to Maintain Listing...

Financial Statements

Financial Results

Nasdaq Compliance

Financial Results

Stock Split Approval

Nasdaq Compliance Extension

CEO Resignation

Management Changes

Agreement for Stock and War...

Financial Results Announcement

Results of Operations and F...

Financial Results Announcement

Financial Results Announcement

Financial Results and FDA A...

Annual Meeting Results

Meeting Adjournment

Financial Results Announcement

Underwriting Agreement

Financial Results

Financial Results Announcement

External Links:

Francois Michelon resigned as CEO of Endra Life Sciences on August 12, 2024, and Alexander Tokman was appointed as the acting CEO effective August 13, 2024; Michelon will receive four months' salary and healthcare benefits as part of his separation agreement.

AI Assistant

ENDRA LIFE SCIENCES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.